about
Onchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex.Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasisHuman Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination ProgrammeTime series analysis of onchocerciasis data from Mexico: a trend towards elimination.Onchocerciasis transmission in Ghana: biting and parous rates of host-seeking sibling species of the Simulium damnosum complex.Potential effects of warmer worms and vectors on onchocerciasis transmission in West Africa.Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys.Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.Human infection patterns and heterogeneous exposure in river blindness.Transmission dynamics of lymphatic filariasis: vector-specific density dependence in the development of Wuchereria bancrofti infective larvae in mosquitoes.Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors.Bayesian geostatistical prediction of the intensity of infection with Schistosoma mansoni in East Africa.The effect of a high-fat breakfast on the pharmacokinetics of moxidectin in healthy male subjects: a randomized phase I trialRequired duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal.Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.Measuring and modelling the effects of systematic non-adherence to mass drug administration.Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects.Transmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa.Antibody responses in onchocerciasis as a function of age and infection intensity.The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans.Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments.Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?Scaling for Dynamical Systems in Biology.Modelling the impact of larviciding on the population dynamics and biting rates of Simulium damnosum (s.l.): implications for vector control as a complementary strategy for onchocerciasis elimination in Africa.ONCHOCERCOSIS MANSONELLA CO-INFECTION PRESENTING AS A SUBCUTANEOUS NODULE IN A CHILDSubstantiating freedom from parasitic infection by combining transmission model predictions with disease surveys
P2860
Q26315231-B2B72EC2-1F19-42EF-9802-8A9C8C66B7A1Q28487047-D04985D4-B841-4B52-80FF-E2A342B2B1B6Q28546650-0BD370B8-4F7B-4D00-A030-07FE009C0243Q30596655-E2C078E7-B86E-4EEA-9FDA-72D8D53910F7Q30602955-15A95D9A-5BBF-429D-A055-749772181BE8Q30894025-F4B477BE-5615-4E6B-8D6A-68B5F2A9F23EQ33468406-BD940E49-D944-4FC6-8296-12AA62D08F24Q33681574-106FC9CC-9464-475D-90CC-D3878B77990CQ34084959-E0F68402-389A-4D1D-96C4-74375035C097Q34574249-A2C07A0F-79FB-4AF6-9B45-CB75895A6EB2Q34654304-2458E33B-48DA-47D8-9B81-0607BFFA12B0Q35510635-674C20C7-BFEC-4E79-92B8-50E7147AFAF8Q35613736-990D508A-8A4D-43B4-94A5-FC52BB783A33Q35637063-DD10D3AB-3665-488F-BECC-14484D82ABB0Q36201881-AFCAA468-56DA-4FCA-9C75-B1E9BBC64C29Q36303283-D733A341-1AF1-4B23-A411-849048748962Q37006791-B03353EE-5788-4143-8295-6435BB0BEA67Q37377289-E79D98FD-CF09-438B-A09A-D4C61D1F52EDQ38916889-0411FA0B-7D7B-4092-A626-160D5B1770D9Q39810406-42979D36-DED4-4163-9CF1-82908CC3DBA9Q43687527-E980B4AF-5E6C-4984-97FD-A41BA07F3C44Q44571474-7DA88DCF-3307-49DA-B8B8-A7FE5FC44E72Q44601138-9DF908CD-02FC-4E9D-B234-9E702D8C48D4Q45770627-AA873260-76FD-4A34-B08B-DF0B3269FB3FQ46768706-B3CAABDF-57E4-4BC7-BD6D-7C0E768B67BAQ47676905-8B2726BE-2E94-4E08-BD29-7C981481F164Q55401692-7F2018F4-4E07-4CD0-B7FA-CA08AB48F9CFQ57828348-031855D3-0C25-4073-A315-E73F2498E440Q58600294-00186BAA-8123-42BC-9781-FF10FE61AECA
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Population biology of human onchocerciasis.
@ast
Population biology of human onchocerciasis.
@en
type
label
Population biology of human onchocerciasis.
@ast
Population biology of human onchocerciasis.
@en
prefLabel
Population biology of human onchocerciasis.
@ast
Population biology of human onchocerciasis.
@en
P2860
P356
P1476
Population biology of human onchocerciasis.
@en
P2093
M Boussinesq
M G Basáñez
P2860
P304
P356
10.1098/RSTB.1999.0433
P407
P577
1999-04-01T00:00:00Z